Valuation: Legend Biotech Corporation

Market Cap 4.23B 3.62B 3.39B 3.1B 5.82B 405B 5.9B 40.04B 15.61B 203B 15.88B 15.53B 672B P/E 2026 *
2,681x
P/E 2027 * 24.7x
Enterprise Value 3.29B 2.82B 2.64B 2.42B 4.53B 315B 4.59B 31.17B 12.16B 158B 12.36B 12.09B 523B EV / Sales 2026 *
2.3x
EV / Sales 2027 * 1.74x
Free-Float
99%
Yield 2026 *
-
Yield 2027 * -
1 day+2.63%
1 week+7.12%
Current month+17.63%
1 month-7.27%
3 months-25.71%
6 months+20.42%
Current year+0.37%
1 week 20.2
Extreme 20.2
23.24
1 month 18.33
Extreme 18.33
23.24
Current year 16.24
Extreme 16.24
37.5
1 year 16.24
Extreme 16.24
37.5
3 years 16.24
Extreme 16.24
72.38
5 years 16.24
Extreme 16.24
77.32
10 years 16.24
Extreme 16.24
77.32
Manager TitleAgeSince
Chief Executive Officer 54 2026-07-23
Director of Finance/CFO - 2025-08-17
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 2020-11-05
Director/Board Member 69 2020-04-30
Director/Board Member 64 2020-04-30
Date Insider Type Main position Quantity % Market Cap.
8/14/26 Free

Chief Executive Officer

4,908 0.0017%
7/24/26 Other

Chief Executive Officer

30,234 0.0105%
6/30/26 Don

Chief Executive Officer

-3,382 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+2.63%+7.12%-38.64%-68.65% 4.23B
-3.00%+2.27%+73.26%+109.90% 72.12B
+1.90%+23.53%+59.48%+94.82% 65.85B
+5.12%+25.22%+5.13%-5.86% 29.28B
+0.55%+1.64%-4.63%+480.92% 27.47B
+2.74%+12.98%+54.92%+25.77% 26.7B
+0.47%+6.12%+37.01%-15.31% 20.06B
+1.82%-6.67%+251.36%+388.91% 18.22B
+0.94%+3.36%+15.30%+548.19% 16.4B
+0.73%+5.54%+39.99%+151.77% 13.4B
Average +1.39%+8.24%+49.32%+171.05% 29.37B
Weighted average by Cap. +0.77%+9.45%+56.63%+154.60%

Financials

2026 *2027 *
Net sales 1.43B 1.23B 1.15B 1.05B 1.97B 137B 2B 13.58B 5.3B 68.93B 5.38B 5.27B 228B 1.81B 1.55B 1.45B 1.33B 2.49B 173B 2.53B 17.14B 6.69B 87.02B 6.8B 6.65B 288B
Net income -12.85M -11.01M -10.3M -9.43M -17.69M -1.23B -17.93M -122M -47.45M -618M -48.25M -47.2M -2.04B 228M 195M 182M 167M 313M 21.77B 317M 2.15B 840M 10.94B 854M 836M 36.18B
Net Debt -936M -802M -751M -687M -1.29B -89.59B -1.31B -8.87B -3.46B -45.01B -3.52B -3.44B -149B -1.08B -925M -865M -792M -1.49B -103B -1.51B -10.22B -3.99B -51.88B -4.05B -3.96B -172B
Logo Legend Biotech Corporation
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Employees
3,200
Date Price Change Volume
26-08-21 US$21.82 +2.63% 1,424,313
26-08-20 US$21.26 -5.93% 2,768,653
26-08-19 US$22.60 +3.10% 2,639,854
26-08-18 US$21.92 +6.15% 3,643,356
26-08-17 US$20.65 +1.37% 1,267,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
21.82USD
Average target price
49.25USD
Spread / Average Target
+125.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LEGN Stock